|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||1.4000 - 1.4000|
|52 Week Range||0.6030 - 1.6330|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that it has received a final order from the Ontario Superior Court of Justice (Commercial List) approving the previously announced plan of arrangement (the “Arrangement”) with Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018. Assuming the satisfaction or waiver of these remaining closing conditions, it is anticipated that the Arrangement will be completed on or around March 14, 2019.
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia Health” or the “Company”) announced today that the Company has received conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the Toronto Venture Exchange (“TSXV”) and list its common shares on the TSX under the symbol “ALEF”. Listing on the TSX is subject to TSX final approval which is conditional upon the completion of the Company’s previously announced acquisition of Emblem Corp. (TSXV: EMC, OTCQX: EMMBF). In conjunction with listing on the TSX, the common shares will be voluntarily delisted from the TSXV prior to the commencement of trading on the TSX.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) is pleased to announce that, at the special meeting of shareholders of Emblem held today (the “Meeting”), the shareholders of Emblem voted in favour of a special resolution to approve the proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health described in the joint press release issued by Emblem and Aleafia on December 19, 2018, as well as certain other Meeting matters. The Arrangement required approval by 66 ⅔% of the votes cast by shareholders present in person or represented by proxy at the Meeting.
White to Lead Integration of Canabo Medical Clinics and GrowWise Health Post-closing of Emblem AcquisitionPreviously the COO of Canada’s Largest Multidisciplinary Clinic Network.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) announces that the Ontario Superior Court of Justice (Commercial List) granted the Company’s motion for an interim order authorizing various matters, including the mailing of a management information circular (the “Circular”) and the holding of the special meeting of Emblem shareholders to be held on Wednesday March 6, 2019 at 10:30 a.m. (Toronto time) at the offices of Dentons Canada LLP, 77 King Street West, Suite 400, Toronto, Ontario, M5K 0A1 (the “Meeting”). The Meeting will be held to consider the previously announced proposed arrangement (the “Arrangement”) involving Emblem and Aleafia Health Inc. (“Aleafia”) described in the joint press release issued by Emblem and Aleafia on December 19, 2018 (the “Arrangement”), as well as certain other Meeting matters as set out in the Circular mailed to shareholders.
One of the key factors causing the mobilization in political arenas is that the vast majority of the public is in favor of cannabis legalization. When Canada decided to begin selling recreational marijuana on October 17th, it helped to create a domino effect as well as shift the public opinion in showing that a legal adult-wide cannabis industry could work viable. Global Consortium Inc (GCGX), Aleafia Health Inc (ALEAF) (ALEF), Emblem Corp (EMMBF), and HEXO Corp (HEXO) are four pot stocks looking to remain on high this month.
With so many legal initiatives occurring throughout the industry in North America and beyond, the cannabis industry has garnered copious amounts of public approval, resulting in the increase in investor excitement emanating from those looking for promising opportunities. Some studies have shown that the global cannabis industry is worth as much as $50 billion, which, if conditions remain the same, will only grow over time. GTEC Holdings Ltd (TSXV:GTEC) (OTCQB:GGTTF), Emblem Corp (EMMBF) (EMC.V), Charlotte's Web Holdings Inc (CWBHF), and Cronos Group Inc (CRON) represent four companies committed to integrating cannabis as a means of improving the quality of life for consumers on a global scale.
CORAL GABLES, FL / ACCESSWIRE / January 18, 2019 / Marijuana stocks have become one of the hottest topics in the news over the course of the past few years. In terms of the US cannabis market, several states have led by example, in terms of how positive legalization can be on a widespread scale. ParcelPal Technology Inc (PTNYF) (PKG), Emblem Corp (EMMBF), Aurora Cannabis Inc (ACB) (ACB), and New Age Beverages Corp (NBEV) are 4 pot stocks worth looking into on Friday.
Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“Aleafia Health”) or the (“Company”) is announcing its global expansion with the closing of its previously announced investment in CannaPacific Pty Limited (“CannaPacific”), a federally licensed Australian medical cannabis company located in New South Wales, Australia. CannaPacific is licensed by the Office of Drug Control (ODC) of Australia to cultivate medical cannabis (License MC020/18) and to research medical cannabis (License RL 012/18).
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced that Emblem-branded cannabis oils are now available online through Shoppers Drug Mart to patients with a valid medical authorization. Emblem’s state-of-the-art indoor cannabis cultivation facility and Product Innovation Centre is located in Paris, Ontario.
Aleafia Health Inc. (TSXV: ALEF, OTC: ALEAF, FRA: ARAH) (“Aleafia” or the “Company”) has completed Phase I construction and retrofitting of its Niagara Greenhouse facility (“Niagara”) located in Grimsby, Ontario. The Company expects to complete Phase II of the construction and retrofitting on the balance of the facility in late Q1 or early Q2 2019. The Company has also submitted the facility’s Evidence Package to Health Canada, marking the final stage in the Cultivation Licence application process.
The consolidation in the cannabis industry continues as companies not just in the United States are making deals. The company will give 0.8377 shares per each share of Emblem, which represents C$1.21 per Emblem share and a premium of 27 percent based on the closing prices of Aleafia and Emblem on the TSX Venture Exchange on Dec. 18. Cannabis investors can't miss the Benzinga Cannabis Capital Conference, the No. 1 networking event for institutional capital and the leading cannabis companies.
CORAL GABLES, FL / ACCESSWIRE / December 19, 2018 / The price of marijuana can be a very intelligible indicator as to how the market will respond to new trends. As legal markets have gone into place in the U.S., Canada and around the world, we are quickly seeing just how volatile the prices of pure marijuana can be. As more nations around the world pass legislation in favor of marijuana, the cannabis industry may see impressive gains in the near-future.Premier Health Group (OTC:PHGRF) (CSE:PHGI), Emblem Corp (EMMBF), New Age Beverages Corp (NBEV), and Aphria Inc (APHA) represent 4 cannabis stocks that have seen even more activity following ongoing development of legislation.
Combination will create Canada’s largest medical cannabis clinic network with access to 40 medical clinics and education centres;Aleafia patients to access Emblem’s.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through its wholly-owned subsidiary Emblem Cannabis Corporation, today announced the launch of a new line of 10mg Emblem Oil Capsules, providing its growing list of 6,000+ patients with a pre-dosed treatment format. The 10mg Emblem Oil Capsules offer a consistent patient experience formulated with three chemovar specific formats - High THC (10mg THC per capsule), High CBD (10 mg CBD per capsule) and Balanced (6mg THC/10 mg CBD per capsule).
Revenues increase 281% over the quarter ended September 30, 2017 and 50% over Q2 2018 TORONTO, Nov. 20, 2018 -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the.
Canntab Therapeutics Limited (CSE: PILL, FSE: TBF1) (“Canntab” or the “Company”) is a company with a clear vision of becoming the leader in solid oral dosage formulation of cannabis. Their unique products offer advantages to the medical community, patients, adult use consumers and governments. Canntab is pleased to provide this corporate update to its shareholders. A strong intellectual property portfolio with 13 patents pending in the United States and Canada pertaining to the formulation of tablets including instant release, extended release, flash melt and bi-layered. An application to become a Licensed Producer (Non Grower) under the Access to Cannabis for Medical Purposes Regulations and has confirmation from Health Canada that its application had been received.
Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”) today announced the appointment of Connie A. Stefankiewicz and Loreto Grimaldi to its Board of Directors (the “Board”) following Emblem’s annual and special shareholders’ meeting. Harvey Shapiro, current chair, and Maxim Zavet have stepped down from the Board, and the Board would like to thank them for their immense contributions since Emblem’s inception. Ms. Stefankiewicz and Mr. Grimaldi will join current Board members Daniel Milliard, Jeffrey Fineberg, John H. Stewart, Terry Johnson and Nick Dean.
VIDEO + B-ROLL: Emblem Corp. CEO Nick Dean welcomes Canada-wide adult-use cannabis legalization